The Pioneer SCA3 Translational Research Award funds innovative research to advance treatment, understanding, and care for Spinocerebellar Ataxia Type 3, emphasizing translational and clinical impact.
Supports rigorous translational and clinical research to develop effective therapies for ataxia-telangiectasia, with a focus on neurological symptoms and direct therapeutic impact.
The SMA Foundation Research Funding program supports projects that accelerate late-stage translational research or clinical trials for new SMA therapeutics.
Annual grant supporting innovative research to advance understanding, diagnosis, and treatment of multiple system atrophy, cerebellar subtype (MSA-C).
This grant funds innovative pilot research to advance the understanding, mechanisms, or treatment of all forms of ataxia, supporting both translational and foundational studies.
PART and IDEA in Spinal Cord Injury (Round 8) support researchers pursuing translational and innovative studies to advance treatments, restore function, and move toward a cure for paralysis.